Thorburn, D., Fisker, M. J., Xu, J., Wang, Y., Lu, X., Billin, A., … Muir, A. J. (2020). LONGITUDINAL CHANGES OF PRO-C3 AND ELF ARE ASSOCIATED WITH HISTOLOGIC AND CLINICAL DISEASE PROGRESSION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC). In HEPATOLOGY (Vol. 72, pp. 750A-751A).

Thorburn, Douglas, Mette Juul Fisker, Jun Xu, Ya Wang, Xiaomin Lu, Andrew Billin, Ryan Huss, et al. “LONGITUDINAL CHANGES OF PRO-C3 AND ELF ARE ASSOCIATED WITH HISTOLOGIC AND CLINICAL DISEASE PROGRESSION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC).” In HEPATOLOGY, 72:750A-751A, 2020.

Thorburn D, Fisker MJ, Xu J, Wang Y, Lu X, Billin A, et al. LONGITUDINAL CHANGES OF PRO-C3 AND ELF ARE ASSOCIATED WITH HISTOLOGIC AND CLINICAL DISEASE PROGRESSION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC). In: HEPATOLOGY. 2020. p. 750A-751A.

Thorburn, Douglas, et al. “LONGITUDINAL CHANGES OF PRO-C3 AND ELF ARE ASSOCIATED WITH HISTOLOGIC AND CLINICAL DISEASE PROGRESSION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC).” HEPATOLOGY, vol. 72, 2020, pp. 750A-751A.

Thorburn D, Fisker MJ, Xu J, Wang Y, Lu X, Billin A, Huss R, Chung C, Myers RP, Manns MP, Bowlus CL, Levy C, Goodman ZD, Pinzani M, Vesterhus M, Karsdal MA, Muir AJ. LONGITUDINAL CHANGES OF PRO-C3 AND ELF ARE ASSOCIATED WITH HISTOLOGIC AND CLINICAL DISEASE PROGRESSION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC). HEPATOLOGY. 2020. p. 750A-751A.